Clearmind Medicine Inc. (CMND)

NASDAQ: CMND · IEX Real-Time Price · USD

1.153

-0.027 (-2.29%)

Apr 19, 2024, 10:45 AM EDT - Market open

Clearmind Medicine Cash Flow Statement

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Year	2023	2022	2021	2020
Net Income	-8.62	-6.89	-2.73	-0.41
Depreciation & Amortization	0.06	0.08	0	0
Share-Based Compensation	0.37	1.21	0.62	0
Other Operating Activities	1.9	1.88	0.03	0.15
Operating Cash Flow	-6.3	-3.72	-2.08	-0.26
Capital Expenditures	0	-0.01	-0.02	-0.01
Other Investing Activities	-0.03	-	-0.16	0
Investing Cash Flow	-0.03	-0.01	-0.18	-0.01
Share Issuance / Repurchase	11.71	0.58	5.39	0.6
Debt Issued / Paid	-0.04	-0.07	0	0
Financing Cash Flow	11.66	0.51	5.39	0.6
Exchange Rate Effect	-0.04	-0.02	0	0
Net Cash Flow	5.3	-3.24	3.13	0.33
Free Cash Flow	-6.3	-3.73	-2.1	-0.27
Free Cash Flow Per Share	-31.12	-86.08	-67.98	-15.14

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).